Report cover image

2021 IVD Market Update and COVID-19 Impact

Published Mar 01, 2021
Length 54 Pages
SKU # KLI16656590

Description

2021 IVD Market Update and COVID-19 Impact

Description

What is the Size of the IVD Market in 2021?

What Impact has COVID-19 Had on IVD Markets?

What Major Trends are Affecting the Market in 2021?

Diagnostic test products have never been more important. This report, 2021 IVD Market Update and COVID-19 Impact, is an update of the market for in vitro diagnostics products from Kalorama’s analysts to reflect the latest information. As part of its coverage, this report contains market sizing for the following categories of IVD:
  • Clinical Chemistry
  • Immunoassays- non isotopic
  • Infectious disease
  • Other immunos
  • Blood bank screening
  • Drugs of Abuse
  • Diabetes HbA1c – lab
  • Hematology – Core Lab
  • Microbiology (ID/AST)
  • Microbiology (molecular)
  • Microbiology – Mass Spectrometry
  • Radioimmunoassays
  • Coagulation (PT/INR)
  • Coagulation, molecular
  • Histology/cytology
  • HPV, molecular
  • Nucleic acid assays
  • Blood grouping/typing
  • Blood bank molecular
  • NAT Blood Screens
  • Circulating tumor cells
  • POC, OTC diabetes
  • POC, OTC other
  • POC, professional/hospital;
  • COVID 19
Complete market figures and forecasts will be part of Kalorama’s Worldwide report in August.

How is COVID-19 Impacting the Market in 2021

This report does detail the effects of COVID-19 including the following:
  • Effect of COVID-19 on Market Segments
  • Table 1-3: IVD Market excluding and with COVID-19, 2020
  • Figure 1-1: IVD Market Distribution by Segment
  • Table 1-4: Global In Vitro Diagnostic Market – YoY Growth 2019-2020
  • Figure 1-2: Global In Vitro Diagnostic Market – YoY Growth 2019-2020
  • Figure 1-3: IVD Segment Performance, Q1 2020 – Q4 2020
  • Figure 1-4: IVD Segment Performance, Total Market Value, 2020
Also included in this report:
  • Product Trends and Developments
  • COVID-19 Developments Sept. 2020 to Feb 2021
  • Select IVD Market Participant Developments
  • Competitive Leader Updates
Companies covered in this report include:
  • Abbott
  • Aidian Oy
  • Becton Dickinson and Co
  • Biomérieux SA
  • Danaher
  • Hologic, Inc.
  • Illumina
  • Ortho Clinical Diagnostics
  • Perkin Elmer
  • Quidel Corporation
  • Roche Diagnostic
  • Thermo Fisher Scientific

Table of Contents

54 Pages
    • Global In Vitro Diagnostic Sales by Product Market, 2020 ($ million) (Clinical Chemistry; Immunoassays- non isotopic: Infectious disease, Other immunos, Blood bank screening, Drugs of Abuse, Diabetes HbA1c - lab; Hematology - Core Lab; Microbiology (ID/AST); Microbiology (molecular); Microbiology - Mass Spectrometry; Radioimmunoassays; Coagulation (PT/INR); Coagulation, molecular; Histology/cytology; HPV, molecular; Nucleic acid assays; Blood grouping/typing; Blood bank molecular - NAT Screens; Circulating tumor cells; POC, OTC diabetes; POC, OTC other; POC, professional/hospital; Mass Spectrometry)
    • COVID 19
    • IVD Market Highlights
    • New Core IVD Product Launches and Developments
    • COVID-19 Developments – September 2020 and Beyond
    • Selected Competitive Leader Updates
    • Abbott
    • Aidian Oy
    • Becton Dickinson and Co
    • bioMérieux SA
    • Danaher
    • Hologic, Inc.
    • Illumina
    • Ortho Clinical Diagnostics
    • Perkin Elmer
    • Quidel Corporation
    • Roche Diagnostic
    • Thermo Fisher Scientific
    • Telehealth and Remote Patient Monitoring
    • Expanding Options in Reimbursement
    • Point-of-Care
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.